KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Goodwill & Intangibles: 2011-2025

Historic Goodwill & Intangibles for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $29.7 million.

  • Sarepta Therapeutics' Goodwill & Intangibles rose 7.67% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year increase of 7.67%. This contributed to the annual value of $26.9 million for FY2024, which is 9.23% down from last year.
  • Per Sarepta Therapeutics' latest filing, its Goodwill & Intangibles stood at $29.7 million for Q3 2025, which was down 2.75% from $30.5 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Goodwill & Intangibles ranged from a high of $30.5 million in Q2 2025 and a low of $7.2 million during Q1 2023.
  • For the 3-year period, Sarepta Therapeutics' Goodwill & Intangibles averaged around $24.8 million, with its median value being $27.6 million (2024).
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first plummeted by 64.35% in 2022, then surged by 301.86% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Goodwill & Intangibles (Quarterly) stood at $21.3 million in 2021, then tumbled by 64.35% to $7.6 million in 2022, then spiked by 290.87% to $29.6 million in 2023, then decreased by 9.23% to $26.9 million in 2024, then climbed by 7.67% to $29.7 million in 2025.
  • Its Goodwill & Intangibles stands at $29.7 million for Q3 2025, versus $30.5 million for Q2 2025 and $26.2 million for Q1 2025.